Adverum Biotechnologies, Inc.

NASDAQ:ADVM

4.74 (USD) • At close December 24, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q1
Revenue 100-3.6003.60000-7.5007.50000-0.250.25000.070.8330.4930.2160.4610.4630.4630.4620.4880.3950.3070.2650.960.9530.2030.2030.2030.2040.1350.0300.030.150.3
Cost of Revenue 0.890.9560.9971.0091.5097.0433.0191.7121.7881.6031.4257.50.9621.195000000.25000000000000000000000000000
Gross Profit 0.11-0.956-0.997-4.609-1.509-7.0430.581-1.712-1.788-1.603-1.425-15-0.962-1.1957.50000-0.50.25000.070.8330.4930.2160.4610.4630.4630.4620.4880.3950.3070.2650.960.9530.2030.2030.2030.2040.1350.0300.030.150.3
Gross Profit Ratio 0.11001.28000.1610000200100002100111111111111111111110111
Reseach & Development Expenses 20.43917.09715.4115.07820.7420.59921.05922.19923.84930.26522.96422.52424.06922.60819.9822.72816.65319.17714.75111.3749.9448.9710.13111.64214.4811.21712.79412.01410.2728.4929.0617.8988.3627.9557.4557.1927.5235.1265.6217.2265.7463.0940.910.7390.550.6610.201
General & Administrative Expenses 9.7823.78511.42910.8813.78912.46612.7811.74117.18813.7615.16911.89514.45321.9316.16313.65211.35110.5989.048.2797.3897.1325.5765.1874.8269.1795.3684.0424.7624.0647.9894.7776.1465.1148.3185.3747.6314.9594.1433.382.3981.4940.7261.190.2580.1940.141
Selling & Marketing Expenses 07.2440.303-1.0090000000000000000000000000000000000000000000
SG&A 9.78211.02911.7329.87113.78912.46612.7811.74117.18813.7615.16911.89514.45321.9316.16313.65211.35110.5989.048.2797.3897.1325.5765.1874.8269.1795.3684.0424.7624.0647.9894.7776.1465.1148.3185.3747.6314.9594.1433.382.3981.4940.7261.190.2580.1940.141
Other Expenses 02.4062.0521.3111.6611.5761.21.2230.9230.2830.2440.010.160.2050.207-0.1380.2350.5750.8850.7280.9651.1481.2181.11.2651.0930.7460.8060.7420.6630.4890.2180.2060.2220.1160.0850.1170.1160.0520.012-0.026-0.641-0.043-0.102-0.0040.0060.006
Operating Expenses 30.22128.12627.14224.94934.52933.06533.83933.9441.03744.02538.13334.41938.52244.53836.14336.3828.00429.77523.79119.65317.33316.10215.70716.82919.30620.39618.16216.05615.03412.55617.0512.67514.50813.06915.77312.56615.15410.0859.76410.6068.1444.5881.6361.9290.7780.7050.042
Operating Income -30.721-29.082-28.139-25.958-34.529-33.065-30.239-33.94-41.037-44.025-38.133-34.419-38.522-44.538-28.643-36.38-28.004-29.775-23.791-19.653-17.083-16.102-15.707-16.759-23.473-19.903-17.946-15.595-14.571-12.093-16.588-23.387-14.507-61.882-15.508-14.179-14.201-9.882-9.561-10.403-7.94-4.453-1.606-1.929-0.778-0.705-0.042
Operating Income Ratio -30.721007.21100-8.400004.58900-3.819000078.612-68.33200-239.414-28.179-40.371-83.083-33.829-31.471-26.119-35.905-47.924-36.727-201.57-58.521-14.77-14.901-48.68-47.099-51.246-38.922-32.985-53.5330-25.933-4.7-0.14
Total Other Income Expenses Net 3.5872.4063.3521.1111.6611.5761.21.2230.923-1.7280.2440.0190.160.2050.207-0.1380.2350.5750.8850.7280.9651.1481.2181.1-3.7351.0930.7460.8060.7420.6630.4890.218-0.0010.2220.1160.0850.1170.1160.0520.012-0.316-0.641-0.057-1.764-0.035-0.016-0.007
Income Before Tax -27.134-18.476-24.787-24.847-32.868-31.489-29.039-32.717-40.114-43.742-37.889-34.409-38.362-44.333-28.436-36.518-27.769-29.2-22.906-18.925-16.118-14.954-14.489-15.659-22.208-18.81-17.2-14.789-13.829-11.43-16.099-23.169-14.301-61.66-15.392-14.094-14.084-9.766-9.509-10.391-8.256-5.094-1.663-3.693-0.813-0.721-0.049
Income Before Tax Ratio -27.134006.90200-8.06600004.58800-3.791000075.7-64.47200-223.7-26.66-38.154-79.63-32.08-29.868-24.687-34.846-47.477-36.205-200.847-58.083-14.681-14.779-48.108-46.842-51.187-40.471-37.733-55.4330-27.1-4.807-0.163
Income Tax Expense 000.954-1.1330.0170.0210.0170.0190.0170.0190.0190000-1.1140001.2660.5420.5390.5391.25-1.25000000-0.7750.39449.1202.2670.1170.116-0.118-0.079-0.026-0.025-0.029-0.090.0240.0260.019
Net Income -27.134-18.476-24.787-23.714-32.885-31.51-29.056-32.736-40.131-43.761-37.908-34.409-38.362-44.333-28.436-37.632-27.769-29.2-22.906-18.925-16.118-14.954-14.489-15.659-20.958-18.81-17.2-14.789-13.829-11.43-16.099-22.394-14.301-61.66-15.392-14.094-14.084-9.766-9.509-10.391-8.256-5.094-1.663-3.693-0.813-0.721-0.049
Net Income Ratio -27.134006.58700-8.07100004.58800-3.791000075.7-64.47200-223.7-25.16-38.154-79.63-32.08-29.868-24.687-34.846-45.889-36.205-200.847-58.083-14.681-14.779-48.108-46.842-51.187-40.471-37.733-55.4330-27.1-4.807-0.163
EPS -1.3-0.89-1.5-2.34-3.26-3.13-2.9-3.28-0.4-0.44-0.38-0.35-0.39-0.45-0.29-0.39-0.31-0.36-0.31-0.26-0.25-0.23-0.23-0.25-0.34-0.3-0.3-0.26-0.32-0.27-0.38-0.54-0.35-1.76-0.57-0.55-0.55-0.38-0.38-0.46-0.5-0.25-0.08-0.18-0.039-0.035-0.002
EPS Diluted -1.3-0.89-1.5-2.34-3.26-3.13-2.9-3.28-0.4-0.44-0.38-0.35-0.39-0.45-0.29-0.38-0.31-0.36-0.31-0.26-0.25-0.23-0.23-0.25-0.34-0.3-0.3-0.26-0.32-0.27-0.38-0.54-0.35-1.76-0.57-0.55-0.55-0.38-0.38-0.46-0.5-0.25-0.08-0.18-0.039-0.035-0.002
EBITDA -26.244-17.52-27.142-26.126-33.02-24.446-26.02-31.005-38.326-42.139-36.464-33.087-37.4-43.138-27.27-35.441-26.569-27.9-22.307-18.571-15.203-13.995-13.524-16.37-21.946-18.17-16.741-14.285-13.329-10.83-15.583-22.682-14.035-12.419-15.188-13.788-13.96-9.735-9.443-10.312-8.207-5.065-1.64-2.023-0.778-0.694-0.032
EBITDA Ratio -26.244006.9300-7.95800004.41300-3.664000078.612-64.67200-233.857-15.86-39.073-80.958-32.735-30.313-24.952-34.788-2.023-33.585119.547-57.313-9.409-14.526-47.384-47.099-51.246-38.809-32.985-54.6670-25.833-4.613-0.107